Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with ...
来源：康尔诺生物技术文献2017-07-02
Zhang K, Peng Z, Huang X, Qiao Z, Wang X, Wang N, Xi H, Cui J, Gao Y, Huang X, Gao H, Wei B, Chen L. Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer. J Cancer. 2017 Jul 2;8(10):1826-1832. doi: 10.7150/jca.18946.
相关资讯
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients ...
2025-12-08
Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases
2025-12-08
Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of ...
2022-05-18
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine...
2020-04-12
胃癌肝转移诊断与综合治疗中国专家共识（2019版）
2019-05-01